Home / Brands / Shilpa Medicare
Shilpa Medicare Recalls
6 recalls on record · December 16, 2020 to December 16, 2020 · Drugs
December 16, 2020DrugsFDA
Shilpa Medicare Limited recalls Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial, Cytotoxic A
Hazard: CGMP Deviations
December 16, 2020DrugsFDA
Shilpa Medicare Limited recalls Imatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed
Hazard: CGMP Deviations
December 16, 2020DrugsFDA
Shilpa Medicare Limited recalls Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed
Hazard: CGMP Deviations
December 16, 2020DrugsFDA
Shilpa Medicare Limited recalls Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotox
Hazard: CGMP Deviations
December 16, 2020DrugsFDA
Shilpa Medicare Limited recalls Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotox
Hazard: CGMP Deviations
December 16, 2020DrugsFDA
Shilpa Medicare Limited recalls Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, S
Hazard: CGMP Deviations